Back

Transcriptional immunogenomic analysis reveals distinct immunological clusters in pediatric nervous system tumours

Nabbi, A.; Beck, P.; Delaidelli, A.; Oldridge, D. A.; Sudhaman, S.; Zhu, K.; Yang, S. Y. C.; Mulder, D. T.; Bruce, J. P.; Paulson, J. N.; Raman, P.; Zhu, Y.; Resnick, A. C.; Sorensen, P. H.; Sill, M.; Brabetz, S.; Lambo, S.; Malkin, D.; Johann, P. D.; Kool, M.; Jones, D. T. W.; Pfister, S. M.; Jäger, N.; Pugh, T. J.

2022-09-21 genomics
10.1101/2022.09.20.508719 bioRxiv
Show abstract

To inform immunotherapy approaches in children, we performed an immunogenomic analysis of RNA-seq data from 925 treatment-naive pediatric nervous system tumours (pedNST) spanning 12 cancer types from three public data sets. Within pedNST, we uncovered four broad immune clusters: Pediatric Inflamed (10%), Myeloid Predominant (30%), Immune Neutral (43%) and Immune Excluded (17%). We validated these clusters using immunohistochemistry, methylation immune inference, and segmentation analysis of tissue images. We report shared biology of these immune clusters within and across cancer types, and characterization of specific immune-cell frequencies as well as T- and B-cell repertoires. We found no associations between immune infiltration levels and tumour mutational burden, although molecular cancer entities were enriched within specific immune clusters. Given the heterogeneity within pedNST, our findings suggest personalized immunogenomic profiling is needed to guide selection of immunotherapeutic strategies.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.